Cargando…

Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain

BACKGROUND: Diabetic retinopathy (DR) is a chronic diabetes complication. People with Type 2 Diabetes Mellitus (T2DM) have two times the risk for dementia, suggesting it is a new chronic diabetes complication. OBJECTIVE: Evaluate the association of DR with cognitive performance in a T2DM population....

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida Faria, Ana Cristina Ravazzani, Dall'Agnol, Joceline Franco, Gouveia, Aline Maciel, De Paiva, Clara Inácio, Segalla, Victoria Chechetto, Ogata, Fernando Eiji, Baena, Cristina Pellegrino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617788/
https://www.ncbi.nlm.nih.gov/pubmed/35929625
http://dx.doi.org/10.2174/1573399819666220805154638
_version_ 1785129650490441728
author de Almeida Faria, Ana Cristina Ravazzani
Dall'Agnol, Joceline Franco
Gouveia, Aline Maciel
De Paiva, Clara Inácio
Segalla, Victoria Chechetto
Ogata, Fernando Eiji
Baena, Cristina Pellegrino
author_facet de Almeida Faria, Ana Cristina Ravazzani
Dall'Agnol, Joceline Franco
Gouveia, Aline Maciel
De Paiva, Clara Inácio
Segalla, Victoria Chechetto
Ogata, Fernando Eiji
Baena, Cristina Pellegrino
author_sort de Almeida Faria, Ana Cristina Ravazzani
collection PubMed
description BACKGROUND: Diabetic retinopathy (DR) is a chronic diabetes complication. People with Type 2 Diabetes Mellitus (T2DM) have two times the risk for dementia, suggesting it is a new chronic diabetes complication. OBJECTIVE: Evaluate the association of DR with cognitive performance in a T2DM population. METHODS: Cross-sectional study with 400 T2DM adults from whom socio-demographic, clinical, laboratory data were collected, and screening test for depression symptoms (Patient Health Questionaire-9 (PHQ-9)), Mini-Mental State Examination (MMSE), Semantic Verbal Fluency Test, Trail Making Test A and B, Word Memory test were performed. All cognitive test scores were converted into Global Cognition z-Score (GCS(z)). The association between GCS(z) < 0 with DR was performed using a multivariate binary logistic regression model adjusted for age ≥ 65 years, school years ≤ 6 years, DM duration ≥ 10 years, depression symptoms score > 9 at PHQ-9, arterial hypertension, physical activity, diabetic retinopathy, macular edema, and cardiovascular disease. RESULTS: After exclusions, the 251 eligible patients were 56.6% female, with a mean age of 61.1 (±9.8) years, DM duration of 12.6 (±8.9) years, and 7.6 (±4.2) years of school education. DR prevalence was 46.5%. Multivariate Logistic Regression Model showed an association between DR and GCS(z) < 0, with odds ratio (CI95%) of 2.50 (1.18-5.34), adjusted for age, low education level, arterial hypertension and depression symptoms (OD and CI95% respectively: 5.46(2.42-12.34); 12.19 (5.62-26.46); 2.55 (0.88-7.39); 3.53 (1.55-8.07)). CONCLUSION: In this T2DM population, having DR increased the chance for worse cognitive performance even when adjusted for age, low education level, presence of arterial hypertension, and depression symptoms.
format Online
Article
Text
id pubmed-10617788
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-106177882023-11-01 Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain de Almeida Faria, Ana Cristina Ravazzani Dall'Agnol, Joceline Franco Gouveia, Aline Maciel De Paiva, Clara Inácio Segalla, Victoria Chechetto Ogata, Fernando Eiji Baena, Cristina Pellegrino Curr Diabetes Rev Medicine, Endocrinology, Biochemistry, and Molecular Biology, Pharmacology BACKGROUND: Diabetic retinopathy (DR) is a chronic diabetes complication. People with Type 2 Diabetes Mellitus (T2DM) have two times the risk for dementia, suggesting it is a new chronic diabetes complication. OBJECTIVE: Evaluate the association of DR with cognitive performance in a T2DM population. METHODS: Cross-sectional study with 400 T2DM adults from whom socio-demographic, clinical, laboratory data were collected, and screening test for depression symptoms (Patient Health Questionaire-9 (PHQ-9)), Mini-Mental State Examination (MMSE), Semantic Verbal Fluency Test, Trail Making Test A and B, Word Memory test were performed. All cognitive test scores were converted into Global Cognition z-Score (GCS(z)). The association between GCS(z) < 0 with DR was performed using a multivariate binary logistic regression model adjusted for age ≥ 65 years, school years ≤ 6 years, DM duration ≥ 10 years, depression symptoms score > 9 at PHQ-9, arterial hypertension, physical activity, diabetic retinopathy, macular edema, and cardiovascular disease. RESULTS: After exclusions, the 251 eligible patients were 56.6% female, with a mean age of 61.1 (±9.8) years, DM duration of 12.6 (±8.9) years, and 7.6 (±4.2) years of school education. DR prevalence was 46.5%. Multivariate Logistic Regression Model showed an association between DR and GCS(z) < 0, with odds ratio (CI95%) of 2.50 (1.18-5.34), adjusted for age, low education level, arterial hypertension and depression symptoms (OD and CI95% respectively: 5.46(2.42-12.34); 12.19 (5.62-26.46); 2.55 (0.88-7.39); 3.53 (1.55-8.07)). CONCLUSION: In this T2DM population, having DR increased the chance for worse cognitive performance even when adjusted for age, low education level, presence of arterial hypertension, and depression symptoms. Bentham Science Publishers 2023-08-02 2023-08-02 /pmc/articles/PMC10617788/ /pubmed/35929625 http://dx.doi.org/10.2174/1573399819666220805154638 Text en © 2023 Bentham Science Publishers https://creativecommons.org/licenses/by/4.0/© 2023 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode)
spellingShingle Medicine, Endocrinology, Biochemistry, and Molecular Biology, Pharmacology
de Almeida Faria, Ana Cristina Ravazzani
Dall'Agnol, Joceline Franco
Gouveia, Aline Maciel
De Paiva, Clara Inácio
Segalla, Victoria Chechetto
Ogata, Fernando Eiji
Baena, Cristina Pellegrino
Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain
title Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain
title_full Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain
title_fullStr Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain
title_full_unstemmed Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain
title_short Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain
title_sort cognitive performance and diabetic retinopathy: what your eyes can reveal about your brain
topic Medicine, Endocrinology, Biochemistry, and Molecular Biology, Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617788/
https://www.ncbi.nlm.nih.gov/pubmed/35929625
http://dx.doi.org/10.2174/1573399819666220805154638
work_keys_str_mv AT dealmeidafariaanacristinaravazzani cognitiveperformanceanddiabeticretinopathywhatyoureyescanrevealaboutyourbrain
AT dallagnoljocelinefranco cognitiveperformanceanddiabeticretinopathywhatyoureyescanrevealaboutyourbrain
AT gouveiaalinemaciel cognitiveperformanceanddiabeticretinopathywhatyoureyescanrevealaboutyourbrain
AT depaivaclarainacio cognitiveperformanceanddiabeticretinopathywhatyoureyescanrevealaboutyourbrain
AT segallavictoriachechetto cognitiveperformanceanddiabeticretinopathywhatyoureyescanrevealaboutyourbrain
AT ogatafernandoeiji cognitiveperformanceanddiabeticretinopathywhatyoureyescanrevealaboutyourbrain
AT baenacristinapellegrino cognitiveperformanceanddiabeticretinopathywhatyoureyescanrevealaboutyourbrain